When Cassian said this, Luo Tianming, who was listening to the negotiation, was very surprised.
Because in Luo Tianming's view, the cooperation agreement proposed by Bristol-Myers Squibb is quite superior.
Including the right to use immune drugs and the agency and use rights of tumor-targeted drugs.
These things are quite valuable.
Take pd1 tumor-targeted drugs as an example.
Among the major pharmaceutical companies in the world, only Bristol-Myers Squibb has drugs to treat this type of tumor.
Most tumors of this type are similar to incurable lung cancer.
With the economic and social development of Xia State, while people's living standards are getting higher and higher, pollution relief is becoming more and more serious.
Although experts have repeatedly said that there is no clear connection between environmental pollution and lung cancer.
But in fact, the number of people suffering from lung cancer has increased in recent years.
Ten years ago, it was rare to hear that someone close to you died of lung cancer.
But today, 10 years later, everyone has a relative or friend who died of lung cancer.
Lung cancer has become the number one cancer in Xia.
There is definitely no cure for lung cancer.
This is also an internationally recognized fact.
Including Changtian Technology’s combined colony therapy, there is no way to cure lung cancer.
Because the root cause of lung cancer is cancer, and problems with the lungs are secondary.
Tumor cells in the lungs can metastasize.
Lung cancer often metastasizes to many locations in the head, kidneys, and liver.
At this time, even if Changtian Technology uses combined colony therapy to treat the lung disease, there will be no way to cure the cancer cells that have migrated to other locations.
Especially for small cell lung cancer, the survival rate is very low, and the time from diagnosis to death may only be a few months.
But what is the role of Bristol-Myers Squibb's drugs?
Its function is to accurately kill cancer cells and prolong the patient's survival time through targeted drugs.
This targeted drug certainly does not completely cure late-stage cancer, but it can be more successful in curing early-stage cancer, controlling mid-stage cancer, and prolonging the survival time of patients with late-stage cancer.
There is only one life in this world.
After getting cancer, you face death.
Many people are willing to give everything they have just to cure their cancer or to live a few more years.
Especially those rich people, even if they know that targeted drugs cannot completely cure cancer, they will still spend a lot of money to buy them and try to use them, because they think that they will make money even if they live one more year.
So Chen Xiao kept saying one thing.
What monopoly business is the most profitable?
The monopoly on life is the most profitable.
Bristol-Myers Squibb's targeted tumor drugs are a monopoly on life.
Shanghai Pharmaceuticals Corporation sent experts and teams to the United States last year to negotiate with Bristol-Myers Squibb, with the new purpose of introducing targeted therapy technology.
But it is a pity that the negotiations did not go smoothly.
Bristol-Myers Squibb was simply unwilling to hand over various technologies to Xia Guoren as an agent.
Because if various technologies are handed over to Xia Guoren as an agent, Bristol-Myers Squibb's profits will be much lower.
Now even if they have not approached Xia Guo Company as an agent, their targeted drugs have flowed into Xia Guo's market through various channels, and they are priced at high premiums and high profits.
For example, a cycle of targeted therapy drugs may only be sold for a few thousand dollars in the United States, but if it gets into the hands of patients in Xia through some unfair means, it may cost tens of thousands or even hundreds of thousands of dollars, or even more.
expensive.
After the huge profits were taken away by Bristol-Myers Squibb, the antiseptic drug dealers and even clinical doctors would take a commission from it.
Qu Ping studied medicine, and she knew that some of the professors she had come into contact with specialized in selling overseas drugs to patients.
These drugs are ridiculously expensive.
In addition to purchasing the goods through unfair channels and having high prices, doctors and professors also have to draw commissions from the products.
A box of medicine costs tens of thousands of dollars, and it is easy for a doctor to get a commission of several thousand dollars.
In 2007, in places like Shanghai, a doctor's monthly salary was only a few thousand yuan.
Maybe the commission from a life-saving drug is worth one year's salary.
Many patients who get cancer really trade money for their lives.
The patients are the real leeks and the real fat sheep. Let some pharmaceutical dealers and doctors without professional ethics cut the leeks and pluck the wool over and over again.
When will wool harvesting be stopped?
The patient went bankrupt and took out countless loans for medical treatment, but in the end he was not cured. After losing his life, he would not be plundered.
In this case, only a fool would choose to give up the agency.
Luo Tianming did not expect that the Shanghai Pharmaceutical Corporation would come directly to Changtian Technology to give it to Changtian Technology after spending so much money.
This is the charm of science and technology.
Changtian Technology has powerful enough technology to awe Squibb, so they are willing to cooperate.
Everyone looked at Qu Ping, waiting for Qu Ping's reply.
In fact, to be fair, Bristol-Myers Squibb's conditions are indeed very favorable.
In addition to the agency rights for some of the previous immune drugs and tumor-targeted drugs.
The most important thing is that Bristol-Myers Squibb has good cooperation with the medical department in the United States.
If we can cooperate with Bristol-Myers Squibb, it will definitely be conducive to the promotion and application of combined colony therapy on a global scale.
Especially in the United States.
FDA licenses are difficult to obtain.
But if Bristol-Myers Squibb is coordinating it, United Army's therapy is likely to be available in treatment clinics and large hospitals in the United States in just a few years.
The United States is the most developed country in high-end medical care.
If this technology can be marketed for treatment in the United States, Changtian Technology will definitely make a lot of money.
However, before Qu Ping received Cassian and his party, Chen Xiao had already greeted Qu Ping in advance.
If Bristol-Myers Squibb wants to cooperate with Changtian Technology, there is only one way to go.
That is Bristol-Myers Squibb as the agent of Changtian Technology.
Rather than Changtian Technology transferring all its technology to Bristol-Myers Squibb.
There is no other way of cooperation.
As for the targeted therapy of related tumor drugs.
This is indeed a huge market.
However, this market is currently not practical for most patients in Xia State.
Because targeted therapy is quite expensive, not all patients can afford it.
Most of the people who can afford this treatment are the wealthy people of Xia State.
As for these wealthy people in the Xia Kingdom, even if they don't have any agents in the country, they will still find ways to purchase medicines from the United States.
Luo Tianming felt very nervous.
Of course, he is very much looking forward to the cooperation between Changtian Technology and Bristol-Myers Squibb.
Because only these two companies have reached a cooperation, then Shanghai Pharmaceuticals Corporation will have the opportunity to cooperate with Changtian Technology to promote targeted drug treatments.
However, the protagonists of the negotiations at this time were Changtian Technology and Bristol-Myers Squibb, and Luo Tianming was just a spectator.
Therefore, he has no right to make suggestions, let alone the right to speak.
Cassian was also very nervous at this time.
He is quite clear that if this cooperation is successful, the market involved will be tens of billions or even hundreds of billions of dollars.
He was very worried about Ms. Qu Ping, who looked very old-fashioned, and refused to cooperate directly.
So Kashin said very kindly: "Ms. Qu Ping, we are not in a hurry to answer this matter immediately. I hope you can report it to Changtian Technology Headquarters, especially to Mr. Chen Xiao."
Just when everyone was looking forward to it.
Qu Ping smiled and said: "Mr. Cassian, the door to cooperation is always open, but our cooperation conditions are slightly different from those just proposed by Mr. Cassian."
Cassian also smiled and said: "I am willing to hear the details."
Qu Ping said very calmly: "There is only one condition for cooperation, that is, Bristol-Myers Squibb can be called the agent of Changtian Technology, and you have the right to sell and provide Changtian Technology's combined colony treatment method in North America."
As soon as these words came out, the expressions of the entire Bristol-Myers Squibb team changed.
What kind of company is Bristol-Myers Squibb?
It is one of the largest medical companies in the world.
Their medicines are popular all over the world.
Their treatment technology is world-leading.
Only other companies have ever wanted to cooperate with Bristol-Myers Squibb and become Bristol-Myers Squibb's agents.
There is no situation where Bristol-Myers Squibb becomes someone else's agent.
What Bristol-Myers Squibb wants is this complete treatment technology, and Changtian Technology is just part of Bristol-Myers Squibb's global money-making plan.
The reason why Chen Xiao put forward such a condition.
The most important reason is that he has clearly seen the essence of the combined colony treatment method.
Because even if we don’t cooperate with Bristol-Myers Squibb.
Those wealthy American patients will also try their best to get Xia Guo's treatment.
If Changtian Technology wants to make money.
Then the best way is to cooperate with more Xiaguo hospitals.
Let these hospitals add specialist outpatient and specialist inpatient units for combined colony therapy.
Not only do we accept a large number of national patients, we also accept a large number of foreign patients.
Whether or not to cooperate with Bristol-Myers Squibb will not affect Changtian Technology's profits.
This kind of gap is absolutely unacceptable to Cassian.
Luo Tianming and others were also very surprised. He did not expect that the conditions proposed by Changtian Technology would be so harsh.
Cassian showed a very embarrassed smile and talked for a long time, talking about loneliness.
Moreover, Qu Ping seems to have no interest in targeted therapy technology at all.
In fact, it is not that Changtian Technology has no interest in targeted therapy technology, but Chen Xiao is confident that as technology upgrades and more and more technology trees are lit up, Chen Xiao will be able to find a way to treat malignant tumors sooner or later.
Moreover, this method will definitely be made more advanced and more effective by the so-called targeted therapy technology.
Snyder and other Bristol-Myers Squibb staff looked very unhappy.
Cassian added: "Ms. Qu Ping, I think the conditions we proposed are very reasonable. This is the best way for Changtian Technology to promote various technologies globally."
"You should also know that Europe and the United States have medical systems that are completely different from Xia's."
These words actually have some threatening meaning.
That is to say, if Changtian Technology does not cooperate with Bristol-Myers Squibb, it will be even more difficult for this technology to go abroad and enter the American or European markets.
At present, the say in world medical technology is still in the hands of Westerners.
If combined colony therapy is not recognized by Western society, then this treatment method, like the traditional Chinese medicine of Xia Kingdom, will never be able to enter the world.
Moreover, if Changtian Technology and Bristol-Myers Squibb fail to negotiate, given Bristol-Myers Squibb's influence in the global pharmaceutical industry.
Combined colony therapy may even be demonized by the entire Western society and the international medical community.
Just as it is currently recognized internationally that traditional Chinese medicine cannot fully cure diseases and even has a large number of side effects.
In many countries, TCM treatment is completely banned.
Qu Ping smiled and nodded and said: "Of course I know, sir, otherwise you wouldn't have come all the way to Tianyue Island of Changtian Technology."
Both sides have reached this point.
There is nothing left to talk about.
Cassian looked at Luo Tianming who was sitting beside him. He still had many trump cards in his hand.
However, he was unwilling to continue negotiations with Qu Ping.
Cassian stood up and said: "There are so many interruptions today, but we still hope that both parties can reach cooperation."
Cassian's team left Tianyue Island, and they will also go to Suzhou, Hangzhou and Shanghai to communicate and hold discussions with local management departments and hospitals.
Qu Ping immediately reported today's negotiations to Chen Xiao.
Chen Xiao said: "Bristol Squibb doesn't have many means to restrict us, but we must be prepared for a reduction in overseas patients."
Overseas customers are Changtian Technology’s cash cow.
If there are fewer overseas clients, the cost of treating domestic patients will increase.
This is definitely not in line with Changtian Technology’s working principle of “robbing the rich and giving to the poor”.
If the cost of combined colony treatment is not reduced, if the cost of treatment for domestic patients increases significantly, it will definitely affect the patients' willingness to come for treatment.
The number of patients has decreased, and combined colony therapy has lost its significance.
But all this is a story for later.
On the second day after Cassian's team left Tianyue Island.
Chen Xiao received several calls.
These phone calls surprised Chen Xiao.
The callers include the leaders of Xia Guo's medical-related departments, the chairman of the Shanghai Pharmaceutical Corporation, and even the relevant leaders of the Medical Treatment Center of Xia Guo Academy of Sciences, including Chen Xiao's old friend Professor Wu Yong.
These people have only one purpose for calling.
I just hope that Changtian Technology can reach a cooperation agreement with Bristol-Myers Squibb.
Although Wu Yong did not express this intention, he still hopes that Changtian Technology and Bristol-Myers Squibb will continue to negotiate.
These phone calls left Chen Xiao stunned.
Chen Xiao asked Wu Yong directly.
"Professor Wu, do you know what conditions this Bristol-Myers Squibb proposed?"
"They hope that Changtian Technology can transfer the combined colony treatment technology to them."
"You should know the importance of this technology to Xia Guo."
With the technology of Changtian Technology mobile phone, Changtian Technology can also control the treatment and charging scale, allowing more Xiaguo patients to receive treatment at a lower price.
If the technology is transferred to this hungry wolf that eats people without spitting out bones.
Not to mention the soaring cost of treatment, Changtian Technology will also lose the initiative.
Wu Yong smiled bitterly and said: "Isn't the domestic market still in your hands? What they want is the international market, and some things are not as simple as you think."